Объем 2, Проблема 2 (2012)
Методология клинического исследования
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Обзор: Результаты клинического исследования
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Методология клинического исследования
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Методология клинического исследования
New considerations in the design of clinical trials for traumatic brain injury
Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
Обновление исследований
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Обзор: Результаты клинического исследования
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Обзор: Результаты клинического исследования
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Перспектива клинического исследования
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Терапевтическая перспектива
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
